Follow the people · Insider
Rosty Raykov
Rosty Raykov files insider transactions with the SEC as a chief executive officer of Fennec Pharmaceuticals (FENC). We hold 9 disclosed purchases and sales filed since 20 August 2010, 3 of them in the last 90 days.
- Files forFENC
- Disclosed buys and sells9 in all, 3 in the last 90 days
- Last disclosure1 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 February 2018 — 1 September 2026Chief Executive Officer · Fennec Pharmaceuticals (FENC)136 Form 4 lines · source: SEC Form 4
- Filed 18 August 2010 — 18 August 2010Na · Adherex Technologies (ADHXF)1 Form 4 line · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- was granted 2,778 shares of Fennec PharmaceuticalsSEC Form 41 September 2026Common shares · traded 31 August 2026 · filed 1 September 2026
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 41 September 2026Common shares · traded 1 September 2026 · filed 1 September 2026
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 44 August 2026Common shares · traded 3 August 2026 · filed 4 August 2026
- was granted 2,778 shares of Fennec PharmaceuticalsSEC Form 43 August 2026Common shares · traded 31 July 2026 · filed 3 August 2026
- was granted 2,778 shares of Fennec PharmaceuticalsSEC Form 42 July 2026Common shares · traded 1 July 2026 · filed 2 July 2026
- exercised options over 15,597 shares of Fennec PharmaceuticalsSEC Form 42 July 2026Common shares · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 9,599 shares of Fennec PharmaceuticalsSEC Form 42 July 2026Common shares · traded 1 July 2026 · filed 2 July 2026
- exercised options over 15,597 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 42 July 2026Stock Options · traded 1 July 2026 · filed 2 July 2026
- was granted 2,778 shares of Fennec PharmaceuticalsSEC Form 42 June 2026Common shares · traded 31 May 2026 · filed 2 June 2026
- exercised options over 15,597 shares of Fennec PharmaceuticalsSEC Form 42 June 2026Common shares · traded 1 June 2026 · filed 2 June 2026
- ▼ sold on the open market 9,747 shares of Fennec PharmaceuticalsSEC Form 42 June 2026Common shares · traded 1 June 2026 · filed 2 June 2026
- exercised options over 15,597 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 42 June 2026Stock Options · traded 1 June 2026 · filed 2 June 2026
- exercised options over 2,778 shares of Fennec PharmaceuticalsSEC Form 41 May 2026Common shares · traded 30 April 2026 · filed 1 May 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 41 May 2026Common shares · traded 1 May 2026 · filed 1 May 2026
- ▼ sold on the open market 10,781 shares of Fennec PharmaceuticalsSEC Form 41 May 2026Common shares · traded 1 May 2026 · filed 1 May 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 41 May 2026Stock Options · traded 1 May 2026 · filed 1 May 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 42 April 2026Common shares · traded 31 March 2026 · filed 2 April 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 42 April 2026Common shares · traded 1 April 2026 · filed 2 April 2026
- ▼ sold on the open market 10,946 shares of Fennec PharmaceuticalsSEC Form 42 April 2026Common shares · traded 1 April 2026 · filed 2 April 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 42 April 2026Stock Options · traded 1 April 2026 · filed 2 April 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 2 March 2026 · filed 3 March 2026
- ▼ sold on the open market 10,079 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 2 March 2026 · filed 3 March 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 28 February 2026 · filed 3 March 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Stock Options · traded 2 March 2026 · filed 3 March 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 March 2026Stock Options · traded 2 March 2026 · filed 3 March 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 2 March 2026 · filed 3 March 2026
- ▼ sold on the open market 10,079 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 2 March 2026 · filed 3 March 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 43 March 2026Common shares · traded 28 February 2026 · filed 3 March 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 31 January 2026 · filed 2 February 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 31 January 2026 · filed 2 February 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 2 February 2026 · filed 2 February 2026
- ▼ sold on the open market 10,349 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 2 February 2026 · filed 2 February 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 42 February 2026Stock Options · traded 2 February 2026 · filed 2 February 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 42 February 2026Stock Options · traded 2 February 2026 · filed 2 February 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 2 February 2026 · filed 2 February 2026
- ▼ sold on the open market 10,349 shares of Fennec PharmaceuticalsSEC Form 42 February 2026Common shares · traded 2 February 2026 · filed 2 February 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 31 December 2025 · filed 5 January 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 2 January 2026 · filed 5 January 2026
- ▼ sold on the open market 10,312 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 2 January 2026 · filed 5 January 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 45 January 2026Stock Options · traded 2 January 2026 · filed 5 January 2026
- exercised options over 15,598 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 45 January 2026Stock Options · traded 2 January 2026 · filed 5 January 2026
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 31 December 2025 · filed 5 January 2026
- exercised options over 15,598 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 2 January 2026 · filed 5 January 2026
- ▼ sold on the open market 10,312 shares of Fennec PharmaceuticalsSEC Form 45 January 2026Common shares · traded 2 January 2026 · filed 5 January 2026
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 45 December 2025Common shares · traded 5 December 2025 · filed 5 December 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 42 December 2025Common shares · traded 1 December 2025 · filed 2 December 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 46 November 2025Common shares · traded 5 November 2025 · filed 6 November 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 43 November 2025Common shares · traded 31 October 2025 · filed 3 November 2025
- exercised options over 4,609 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 48 October 2025Stock Options · traded 8 October 2025 · filed 8 October 2025
- exercised options over 4,609 shares of Fennec PharmaceuticalsSEC Form 48 October 2025Common shares · traded 8 October 2025 · filed 8 October 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 46 October 2025Common shares · traded 6 October 2025 · filed 6 October 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 41 October 2025Common shares · traded 30 September 2025 · filed 1 October 2025
- exercised options over 36,207 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 48 September 2025Stock Options · traded 5 September 2025 · filed 8 September 2025
- exercised options over 36,207 shares of Fennec PharmaceuticalsSEC Form 48 September 2025Common shares · traded 5 September 2025 · filed 8 September 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 44 September 2025Common shares · traded 4 September 2025 · filed 4 September 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 42 September 2025Common shares · traded 31 August 2025 · filed 2 September 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 45 August 2025Common shares · traded 5 August 2025 · filed 5 August 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 41 August 2025Common shares · traded 31 July 2025 · filed 1 August 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 47 July 2025Common shares · traded 3 July 2025 · filed 7 July 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 41 July 2025Common shares · traded 30 June 2025 · filed 1 July 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 46 June 2025Common shares · traded 5 June 2025 · filed 6 June 2025
- was granted 5,208 shares of Fennec PharmaceuticalsSEC Form 42 June 2025Common shares · traded 31 May 2025 · filed 2 June 2025
- was granted 33,334 shares of Fennec PharmaceuticalsSEC Form 419 May 2025Common shares · traded 16 May 2025 · filed 19 May 2025
- ▼ sold on the open market 16,667 shares of Fennec PharmaceuticalsSEC Form 419 May 2025Common shares · traded 16 May 2025 · filed 19 May 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 45 May 2025Common shares · traded 5 May 2025 · filed 5 May 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 41 May 2025Common shares · traded 30 April 2025 · filed 1 May 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 44 April 2025Common shares · traded 4 April 2025 · filed 4 April 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 41 April 2025Common shares · traded 31 March 2025 · filed 1 April 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 46 March 2025Common shares · traded 5 March 2025 · filed 6 March 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 428 February 2025Common shares · traded 28 February 2025 · filed 28 February 2025
- ▼ sold on the open market 10,000 shares of Fennec PharmaceuticalsSEC Form 45 February 2025Common shares · traded 5 February 2025 · filed 5 February 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 43 February 2025Common shares · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 47 January 2025Common shares · traded 6 January 2025 · filed 7 January 2025
- ▼ sold on the open market 7,569 shares of Fennec PharmaceuticalsSEC Form 47 January 2025Common shares · traded 6 January 2025 · filed 7 January 2025
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 43 January 2025Common shares · traded 31 December 2024 · filed 3 January 2025
- exercised options over 25,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 423 December 2024Stock Options · traded 20 December 2024 · filed 23 December 2024
- exercised options over 25,000 shares of Fennec PharmaceuticalsSEC Form 423 December 2024Common shares · traded 20 December 2024 · filed 23 December 2024
- ▼ sold on the open market 796 shares of Fennec PharmaceuticalsSEC Form 45 December 2024Common shares · traded 5 December 2024 · filed 5 December 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 44 December 2024Common shares · traded 2 December 2024 · filed 4 December 2024
- ▼ sold on the open market 1,635 shares of Fennec PharmaceuticalsSEC Form 44 December 2024Common shares · traded 3 December 2024 · filed 4 December 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 44 November 2024Common shares · traded 31 October 2024 · filed 4 November 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 44 November 2024Common shares · traded 4 November 2024 · filed 4 November 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 41 October 2024Common shares · traded 30 September 2024 · filed 1 October 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 41 October 2024Common shares · traded 1 October 2024 · filed 1 October 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 44 September 2024Common shares · traded 31 August 2024 · filed 4 September 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 44 September 2024Common shares · traded 4 September 2024 · filed 4 September 2024
- gave away 50,000 shares of Fennec PharmaceuticalsSEC Form 427 August 2024Common shares · traded 23 August 2024 · filed 27 August 2024
- gave away 16,666 shares of Fennec PharmaceuticalsSEC Form 427 August 2024Common shares · traded 23 August 2024 · filed 27 August 2024
- gave away 28,372 shares of Fennec PharmaceuticalsSEC Form 427 August 2024Common shares · traded 23 August 2024 · filed 27 August 2024
- gave away 26,001 shares of Fennec PharmaceuticalsSEC Form 427 August 2024Common shares · traded 23 August 2024 · filed 27 August 2024
- gave away 50,000 shares of Fennec PharmaceuticalsSEC Form 426 August 2024Common shares · traded 23 August 2024 · filed 26 August 2024
- gave away 16,666 shares of Fennec PharmaceuticalsSEC Form 426 August 2024Common shares · traded 23 August 2024 · filed 26 August 2024
- gave away 28,372 shares of Fennec PharmaceuticalsSEC Form 426 August 2024Common shares · traded 23 August 2024 · filed 26 August 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 41 August 2024Common shares · traded 31 July 2024 · filed 1 August 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 41 August 2024Common shares · traded 1 August 2024 · filed 1 August 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 42 July 2024Common shares · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 42 July 2024Common shares · traded 2 July 2024 · filed 2 July 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 43 June 2024Common shares · traded 31 May 2024 · filed 3 June 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 43 June 2024Common shares · traded 3 June 2024 · filed 3 June 2024
- was granted 200,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 421 May 2024Stock Option · traded 16 May 2024 · filed 21 May 2024
- was granted 100,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 421 May 2024Restricted Share Unit · traded 16 May 2024 · filed 21 May 2024
- was granted 2,431 shares of Fennec PharmaceuticalsSEC Form 42 May 2024Common shares · traded 30 April 2024 · filed 2 May 2024
- ▼ sold on the open market 2,431 shares of Fennec PharmaceuticalsSEC Form 42 May 2024Common shares · traded 1 May 2024 · filed 2 May 2024
- ▼ sold on the open market 14,583 shares of Fennec PharmaceuticalsSEC Form 45 April 2024Common shares · traded 4 April 2024 · filed 5 April 2024
- ▼ sold on the open market 29,700 shares of Fennec PharmaceuticalsSEC Form 45 April 2024Common shares · traded 4 April 2024 · filed 5 April 2024
- ▼ sold on the open market 44,300 shares of Fennec PharmaceuticalsSEC Form 45 April 2024Common shares · traded 5 April 2024 · filed 5 April 2024
- ▲ bought on the open market 29,167 shares of Fennec PharmaceuticalsSEC Form 43 April 2024Common shares · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 14,584 shares of Fennec PharmaceuticalsSEC Form 43 April 2024Common shares · traded 3 April 2024 · filed 3 April 2024
- ▼ sold on the open market 26,000 shares of Fennec PharmaceuticalsSEC Form 43 April 2024Common shares · traded 3 April 2024 · filed 3 April 2024
- exercised options over 8,540 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 429 December 2023Commons Shares · traded 28 December 2023 · filed 29 December 2023
- exercised options over 8,540 shares of Fennec PharmaceuticalsSEC Form 429 December 2023Common shares · traded 28 December 2023 · filed 29 December 2023
- ▼ sold on the open market 3,656 shares of Fennec PharmaceuticalsSEC Form 429 December 2023Common shares · traded 28 December 2023 · filed 29 December 2023
- ▼ sold on the open market 17,049 shares of Fennec PharmaceuticalsSEC Form 49 November 2023Common shares · traded 8 November 2023 · filed 9 November 2023
- ▼ sold on the open market 7,995 shares of Fennec PharmaceuticalsSEC Form 49 November 2023Common shares · traded 8 November 2023 · filed 9 November 2023
- exercised options over 74,793 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 November 2023Option Contract · traded 3 November 2023 · filed 3 November 2023
- exercised options over 74,793 shares of Fennec PharmaceuticalsSEC Form 43 November 2023Common shares · traded 3 November 2023 · filed 3 November 2023
- was granted 175,000 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 April 2023Stock Option · traded 31 March 2023 · filed 3 April 2023
- was granted 87,500 shares of Fennec Pharmaceuticals (a derivative holding)SEC Form 43 April 2023Restricted Share Unit · traded 31 March 2023 · filed 3 April 2023
- ▼ sold on the open market 13,740 shares of Fennec PharmaceuticalsSEC Form 430 December 2022Common shares · traded 28 December 2022 · filed 30 December 2022
- ▼ sold on the open market 5,000 shares of Fennec PharmaceuticalsSEC Form 430 December 2022Common shares · traded 29 December 2022 · filed 30 December 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.